IRCT20230222057492N1
The effect of Arctium Lappa root powder in women with polycystic ovary syndrome
Effects of Arctium Lappa root powder on some markers of oxidative stress and inflammation in women with polycystic ovary syndrome: a randomized double blind clinical trial study
Arak University of Medical Sciences·Phase 2/3·Iranian Registry Of Clinical Trial·biologicalRecruiting
Study focus
- Disease/Condition
- Polycystic ovarian syndrome
- Study type
- Interventional
- Intervention type
- biological
Sponsor & location
- Primary sponsor
- Arak University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2/3
- Start date
- Apr 04, 2023
- End date
- N/A
ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionOther and unspecified ovarian cysts
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20230222057492N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20230222057492N1 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Arak University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.